SanBio Company Limited (4592.T)
JPY 762.0
(-4.87%)
JPY 762.0
(-4.87%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 447.22 Million | 741.61 Million |
| Cost of Revenue | 14.5 Million | 24.61 Million | 132.46 Million | 74.45 Million | 446.77 Million | 740.87 Million |
| Gross Profit | -14.5 Million | -24.61 Million | -132.46 Million | -74.45 Million | 447 Thousand | 741 Thousand |
| Operating Expenses | 4.53 Billion | 7.89 Billion | 6.62 Billion | 5.8 Billion | 5.93 Billion | 4.47 Billion |
| Selling, General and Administrative Expenses | 1.69 Billion | 1.78 Billion | 1.66 Billion | 1.73 Billion | 1.6 Billion | 754.49 Million |
| Research and Development Expenses | 2.84 Billion | 6.11 Billion | 4.95 Billion | 4.07 Billion | 4.32 Billion | 3.72 Billion |
| Other Expenses | - | -2.3 Million | 328 Thousand | 237 Thousand | 493.09 Million | 950.86 Million |
| Cost and Expenses | 4.53 Billion | 7.89 Billion | 6.62 Billion | 5.8 Billion | 5.93 Billion | 4.47 Billion |
| Operating Income | -4.53 Billion | -7.89 Billion | -6.62 Billion | -5.8 Billion | -5.48 Billion | -3.73 Billion |
| Interest Expense | 25.81 Million | 25.27 Million | 44.6 Million | 47.17 Million | 47.36 Million | 33.83 Million |
| Income Tax Expense | 102 Million | 862.14 Million | 117.43 Million | 174.37 Million | 1.2 Million | 1.21 Million |
| Earnings before Tax | -2.54 Billion | -4.69 Billion | -4.56 Billion | -3.21 Billion | -5.15 Billion | -2.91 Billion |
| Net Income | -2.64 Billion | -5.55 Billion | -4.67 Billion | -3.38 Billion | -5.15 Billion | -2.92 Billion |
| Earnings Per Share Basic | -40.48 | -95.99 | -90.33 | -65.38 | -100.91 | -60.17 |
| Earnings Per Share Diluted | -40.48 | -95.99 | -90.33 | -65.38 | -100.91 | -60.17 |
| Weighted Average Shares Outstanding | 65.32 Million | 57.91 Million | 51.78 Million | 51.78 Million | 51.11 Million | 48.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.32 Million | 57.91 Million | 51.78 Million | 51.78 Million | 51.11 Million | 48.53 Million |
| Gross Margin | - | - | - | - | 0.00 | 0.00 |
| EBIT Margin | - | - | - | - | -11.31 | -3.84 |
| Profit Margin | - | - | - | - | -11.53 | -3.94 |
| EBITDA | -4.52 Billion | -4.61 Billion | -4.37 Billion | -5.72 Billion | -5.06 Billion | -2.78 Billion |
| Earnings Before Tax Margin | - | - | - | - | -12.27 | -5.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 2.5 Million | 2.44 Million | 2.39 Million | 14.5 Million | 3.48 Million | 4.09 Million |
| Gross Profit | -2.5 Million | -2.44 Million | -2.39 Million | -14.5 Million | -3.48 Million | -4.09 Million |
| Operating Expenses | 905.34 Million | 664.14 Million | 812.06 Million | 4.52 Billion | 640.32 Million | 1.62 Billion |
| Selling, General and Administrative Expenses | 268.02 Million | 277.04 Million | 409.48 Million | - | 305.41 Million | 559.8 Million |
| Research and Development Expenses | 637.31 Million | 387.1 Million | 402.57 Million | - | 334.91 Million | 1.06 Billion |
| Other Expenses | 2.3 Million | 47 Thousand | 1.9 Million | - | 5000.00 | -349 Thousand |
| Cost and Expenses | 905.34 Million | 666.58 Million | 814.45 Million | 4.53 Billion | 640.32 Million | 1.62 Billion |
| Operating Income | -905.34 Million | -666.58 Million | -814.45 Million | -4.53 Billion | -640.32 Million | -1.62 Billion |
| Interest Expense | 2.2 Million | 2.09 Million | 2.34 Million | 25.81 Million | 2.55 Million | 2.77 Million |
| Income Tax Expense | -113.05 Million | 236.07 Million | -38.82 Million | 102.19 Million | 212.3 Million | 168.85 Million |
| Earnings before Tax | -1.27 Billion | 91.22 Million | -800.1 Million | -2.54 Billion | 116.77 Million | -992.51 Million |
| Net Income | -1.16 Billion | -144.85 Million | -761.28 Million | -2.64 Billion | -95.52 Million | -1.16 Billion |
| Earnings Per Share Basic | -17.01 | -2.12 | -11.46 | - | -1.46 | -17.89 |
| Earnings Per Share Diluted | -17.01 | -2.12 | -11.46 | - | -1.46 | -17.89 |
| Weighted Average Shares Outstanding | 68.44 Million | 68.44 Million | 66.42 Million | 65.32 Million | 65.42 Million | 64.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 68.44 Million | 68.44 Million | 66.42 Million | 65.32 Million | 65.42 Million | 64.91 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.27 Billion | -664.14 Million | -812.06 Million | - | 95.56 Million | -989.74 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
FOSECOIND
CMIG3
MCOT
HERF
KAP
PAOTF